设计,合成和生物评估母体衍生物作为潜在的抗乙肝B病毒代理物
Ting-Ting Liu1, Meng-Fan Xie1, Xin Liu1
1Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Biomolecules
|March 28, 2025
概括
新的母体衍生物对乙型肝炎病毒 (HBV) 具有强大的抗病毒活性,为开发慢性乙型肝炎和肝癌的有效治疗提供了有希望的途径.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药用化学 医学化学
背景情况:
- 乙型肝炎病毒 (HBV) 感染会导致进展性肝病,包括肝硬化和肝细胞癌.
- 目前针对HBV的抗病毒疗法存在局限性,例如中等效果,副作用和耐药性.
- 对于具有改进配置文件的新型抗病毒药物有着至关重要的需求.
研究的目的:
- 合成和评估针对HBV的新型母体衍生物的抗病毒活性.
- 为了确定作为HBV治疗药物进一步开发的强效化合物.
主要方法:
- 二十三种母体衍生物的合成.
- 在体外通过测量HBeAg分泌抑制来评估抗病毒活性.
- 强效化合物的IC50值的确定.
- 对选定的化合物进行分子对接研究.
- 在细胞培养模型中评估病毒基因表达和传播抑制.
主要成果:
- 合成的11种母体衍生物显示出显著抑制HBeAg分泌,表现优于阳性对照 lamivudine (3TC).
- 化合物4a和4d表现出最强的抑制活性,IC50值分别为41.78微米和33.68微米.
- 化合物1h,4a和4d在抑制病毒基因表达和细胞培养中的传播方面表现出有效性.
结论:
- 新型母体衍生物对HBV具有显著的抗病毒活性.
- 化合物4a和4d是进一步研究和开发的特别有前途的候选物.
- 这些发现表明,母蛋白衍生物可以作为一种有价值的资源,用于新型抗病毒药物发现乙型肝炎.
相关概念视频
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


